Toggle navigation
Home
Search
Services
Blog
Contact
About
Phase I Single and Multiple-Dose Safety and Pharmacokinetic Clinical S-261025118
University of Pennsylvania IN
Search grants from University of Pennsylvania IN
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Ohio State University
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Immune correlates of long-term success with DAA therapy in HCV/HIV infected people who inject drugs
Dorsoventral functional divergence of the hippocampal CA3 circuit
Gamma Delta T Cells in Lyme Arthritis
Regulation of the MAP kinase pathway in the CD4+ T cells
Chromatin Dynamic Conformation and Radiation Sensitivity
Recently added grants:
Selective galactosylceramidase ablation to study the pathogenesis of Krabbe leukodystrophy
Essential role of Stasimon in motor circuit development and disease
HIV/AIDS Clinical Trials Units University of Cape Town CTU 2020 to 2027
KwaZulu-Natal Clinical Trials Unit
Wits HIV Research Group CLINICAL TRIAL UNIT (CTU) reapplication
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
Division of Cancer Prevention And Control (NCI)
Type
Research and Development Contracts (N01)
Project #
N01CN025118-003
Application #
7191428
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
2005
Total Cost
Indirect Cost
Institution
Name
University of Pennsylvania IN
Department
Type
DUNS #
City
State
Country
Zip Code
Related projects
NIH 2005
N01 CN
Phase I Single and Multiple-Dose Safety and Pharmacokinetic Clinical S-261025118
/ University of Pennsylvania IN
NIH 2004
N01 CN
Phase I Single and Multiple-Dose Safety and Pharmacokinetic Clinical S-261025118
/ University of Pennsylvania IN
Comments
Be the first to comment on this grant